|
Auszug aus dem 10k (annual report) ...Grant Life Sciences has shipped several orders of rapid diagnostic tests for Malaria and Dengue Fever to India. While these initial orders were small due to the lack of funding to expand the purchase and sales, nonetheless it is evidence that we are executing our strategy to revitalize AccuDx’s distributor networks in overseas markets. While we expect revenues to continue to increase, seasonal fluctuations due to the nature of specific diseases will effect monthly sales. For example, Malaria and Dengue Fever are highly seasonal diseases. However, to offset seasonal fluctuations, we plan on broadening our family of diagnostic tests utilized at both the point-of-care as well as in the laboratory setting... Soso, GLIF hat also in 2006 einige Bestellungen für Malaria und Dengue Fieber Schnelltests nach Indien ausgeliefert.... Merkwürdig nur, dass die Umsatzerlöse in 2006 = 0$ sind. Das kann in keinem Fall sein, sofern Schnelltests wirklich verkauft worden sind. Also riecht es hier doch nach klarem Betrug !!! Art |
|
| aus der Diskussion: | Investiert in den Krebsschnelltest |
| Autor (Datum des Eintrages): | Art Bechstein (07.05.07 08:22:56) |
| Beitrag: | 124,081 von 124,359 (ID:29181818) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |